Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesenchymal Stem Cells for Multiple Sclerosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Karolinska Institutet
Sponsor:
Information provided by (Responsible Party):
Ellen Iacobaeus, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01730547
First received: November 9, 2012
Last updated: January 14, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)